Växa
Diabin+ is a Homeopathic Medicinal for Healthier Blood
Sugar Levels
When
a doctor says you have high blood sugar levels, it’s
definitely a wake-up call. This concern and fear leads
you to search ways to prevent the onset of diabetes.
Or, if you’ve been diagnosed with diabetes,
you want information about how to live the healthiest
lifestyle possible.
In addition
to exercise and a proper diet, our homeopathic treatment
for diabetes has shown promise in promoting healthier
blood sugar levels. The ingredients in Växa Diabin+,
a homeopathic medicinal for diabetes, support the
body’s ability to naturally help:
- Use
insulin more efficiently
- Regulate
proper glucose metabolism
- Increase
insulin sensitivity within the circulatory system
Better
yet, under a physician’s care, you can use the
Växa Diabin+ homeopathic treatment for diabetes
in conjunction with your current treatment for both
Type 1 and Type 2 diabetes. Växa Diabin+ is a
natural diabetes treatment that’s both safe
and effective, and it comes with a money-back guarantee.
|
Try Diabin Today RISK FREE with
Växa's 30-Day MONEY BACK Guarantee!
Växa
Diabin+ $27.95
Diabin+'s NDC# is 67514-0214-3
|
Research
shows that when the body has optimal nutrition available
that is specific to pancreatic and Immune System support,
plus the electromagnetic directives to act on that nutritional
input, it can manage insulin production, output and
use more efficiently, and can rebuild pancreatic tissues
and beta cell formations damaged by a diet disproportionately
high in sugars. Växa DIABIN+ is a homeopathic treatment
for diabetes that provides this nutritional support
...
|
|
Diabetes:
Type I
and Type II
Sometimes
we tend to eat too many simple carbohydrates (sugar,
ice cream, crackers and cookies, etc.) which tends
to put a strain on the body’s ongoing ability
to deal with such overly refined foods. Our body,
although miraculous, can wear out when asked to live
off a long-term compromised, overly processed diet.
And when
our diets have become compromised, we usually have
various problems including suffering from the “sugar
blues,” those deep pockets of low energy reserves
that we may feel after a meal (insufficiently balanced
with protein and long-chain carbohydrates) when we
tend to get sleepy and look for the nearest couch.
Unfortunately,
such strain over time can lead to serious problems
of insulin insufficiency and erratic secretion, pancreatic
disease, hormonal imbalance and Insulin receptor abnormalities,
all of which may culminate into diabetes mellitus,
unless the body can be rebalanced and restored through
proper diet.
Växa
Diabin+ is a special scientifically advanced pancreatic
homeopathic medicinal, a homeopathic treatment for
diabetes formulated to provide extra nutritional support
for maintaining appropriate blood sugar levels within
the circulatory system, whether hypo- or hyperglycemic
(prediabetic), or diabetic, as well as to help the
body maintain appropriate insulin sensitivity. Advanced
homeopathic medicinals, with the inclusion of ChromeMate
GTF (a thrice-patented safe chromium source proven
to assist the body in controlling insulin production
and use), are particular and specific for the nutritional
support of diabetes mellitus and diabetic ulcers,
pancreatic disease and other related glandular disorders.
The micro-nutritionals within Växa Diabin+ seek
to aid and support the body in its effort to rebuild
and heal pancreatic tissues and ß-cell formations.
It also works to control insulin management, output,
and use while subsequently decreasing the amount of
sugar in the urine.
Indeed,
diabetes mellitus is the most common of any serious
metabolic disease in humans, and perhaps more than
any other disease, is closely associated with diet.
Moreover, diabetic populations are significantly higher
where western lifestyle and diet habits dominate rather
than those cultures consuming a more “primitive”
diet. Four percent of America now suffers with diabetes;
90% of these are Type II and the remaining 10% are
Type I. The prevalence of diabetes is rising. It’s
now the 7th major cause of death in the U.S., and
it’s thought that this will double every 10-15
years, with an estimated 6-10% increase per year.
Diabetes
mellitus is a chronic disorder of carbohydrate, fat,
and protein metabolism, generally characterized by
fasting elevations of blood glucose levels and erratic
insulin management production, with subsequent increased
chances for developing atherosclerosis, kidney disease,
and loss of nerve function.
Insulin
is a peptide hormone secreted by the ß-cells
of the islets of Langerhans of the pancreas in response
to an elevation in blood glucose or other secretagogues.
It plays a crucial role in glucose homeostasis by
regulating the uptake and metabolism of glucose by
peripheral tissues and the production and storage
of glucose by the liver. Insulin also regulates the
metabolism of lipids and proteins, the synthesis of
nucleic acids and the expression of certain genes.
In some cells, and perhaps in fetal life, insulin
also has a less well-defined role as a growth factor.
Diabetes,
Type I is an Insulin-dependent diabetes (IDDM),
now known to be a T-cell mediated autoimmune disease
specifically targeting the pancreatic beta cells,
a deficiency strongly correlated to a hereditary predisposition
to injury or destruction of pancreatic ß-cells which
produce and secrete Insulin, and the lack of the respective
tissue regenerative power of those cells. The ß-cell
insufficiency and destruction is generally caused
by chemical-pH imbalances and viral or antibody damage
such as that caused by inflammatory cytokines, particularly
those produced by Th1-type lymphocytes, which are
hypothesized to play a major role in the pathogenesis
of all autoimmune diseases, including diabetes of
this type, susceptible to individuals at an early
age - usually childhood onset.
Diabetes, Type II is
a non-Insulin dependent diabetes (NIDDM), being a disorder of glucose
homeostasis characterized by hyperglycemia, peripheral Insulin resistance,
impaired hepatic glucose metabolism, and diminished glucose-dependent
secretion of Insulin from pancreatic ß-cells. This latter defect may lie
in the glucose signaling pathway in ß-cells involving metabolically regulated
Potassium channels which are the targets of sulphonylurea drugs commonly
used in the treatment of NIDDM. Type II is characterized by Insulin insensitivity
evidenced by typically high levels of circulating Insulin and the reversibility
of blood sugar elevation by dietary changes and/or weight loss sufficient
to restore Insulin sensitivity. Low GTF chromium levels are a major determinant
of Insulin insensitivity, and obesity is yet another significant factor;
onset is generally diet related and usually occurs later in life.
Under a
physician’s care, Växa Diabin+ is a safe
and effective for those experiencing Diabetes Type
I and Type II. This homeopathic treatment for diabetes
should not ever be considered a replacement for medical
supervision and treatment. This formula is a special
Advanced homeopathic medicinal which supplements the
body’s natural ability to use insulin more efficiently
in an attempt to avoid the problems listed above,
as well as to use other energy sources when sugar-energies
are erratic and are at a low.
Homeopathic
medicinals within Växa Diabin+ include a number
of herbal phytomedicinals believed to lower blood
glucose levels and quintessential Branched Chain Amino
Acids (BCAAs), which act to increase insulin sensitivity
within the circulatory system, increase appropriate
fatty acid synthesis and may be indirectly involved
with interleukin and interferon secretion by lymph
cells. Indeed, recently BCAAs and other large neutral
Amino Acids have been found to be beneficial when
elevated within the blood plasma of diabetic individuals.
BCAAs may also help to protect against hypertension
and cardiovascular problems now known to be associated
with diabetic onset.
The Prickly
Pear (Opuntia steptacantha, commonly known as “Nopal”
in Mexico) can be found in Växa Diabin+ as well.
In a study reported in Diabetes Care and later in
the Science News, Vol. 133, No.4, January 1988, this
particular desert cactus was shown to lower blood
glucose and insulin levels in diabetics, the authors
believing that the Prickly Pear treatment may improve
the ability of Insulin to efficiently stimulate the
movement of glucose from the blood into body cells.
Växa
Diabin+ is a safe and effective formulation which
is further strengthened with the addition of VäxaTriCardia+
(containing 32-Free Form Amino Acids) and Växa
Systemex, a Lactose-free Meal
Replacement Drink containing Casein and Colostrum.
Indeed,
newly published research indicates that there is now
good and compelling reasons to supply the body with
milk-based proteins, especially those which are predominantly
Casein in nature like those contained within the Växa
Systemex. In this French study originating from the
Sainte-Marguerite Hospital in Marseille, a diet rich
in Casein appears to actually protect subjects (non-obese
mice who have a genetic predisposition for developing
diabetes: NOD mice) from developing diabetes and then
passing it on to their young. Specifically, Casein-fed
NOD female mice were protected against spontaneous
diabetes and male NOD mice against acute Cyclosphosphamide
or Cy-induced diabetes while also lessening the severity
of insulitis.
Moreover,
Casein has been found to exhibit the highest ratio
of Total Essential Amino Acids to total Nitrogen of
all foods and proteins reported by the FAO/WHO Expert
Group.
The specific
Amino Acid configuration of Casein just mentioned
appears to effectively compete against the inflammatory
cytokines response produced by the lymphocytes of
the Immune System mentioned earlier, and may even
reduce or circumvent the possibility of such an aberrant
response, protecting beta cell integrity within the
pancreas and the subsequent production of Insulin
from amino acids derived from its structure. No other
changes in the Immune System could account for these
results. Such may also allow or ensure ß-cell
“rest,” a treatment strategy now of medical
preference.
Interestingly,
egg-based (albumin) proteins and other hydrolyzed
proteins did not demonstrate this "protective" effect;
Subjects fed albumin based proteins developed insulitis
in 10 weeks. This is yet another strong reason for
those who have a family history of diabetes, especially
pregnant or lactating women and children, to supplement
with Växa Systemex and Växa
TriCardia+. Because of the autoimmune
nature of diabetes, supplementation with Växa Immune-Aid+
is also recommended. Växa Immune-Aid+ is formulated
to ensure T-cell integrity and subsequent appropriate
dispersal of those cellular populations throughout
the bloodstream.
The
good news is that with appropriate medical and nutritional support
of the Immune System, and early detection, diabetes may be controlled
and possibly even prevented.
|
Try Diabin Today RISK FREE with
Växa's 30-Day MONEY BACK Guarantee!
Växa
Diabin+ $27.95
Diabin+'s NDC# is 67514-0214-3
|
|
References:
Arfeen S; Goodship
TH; Kirkwood A; Channon S; Ward MK, "1% amino acid peritoneal dialysate:
single-cycle study in diabetic patients with end-stage renal disease,"
Department of Internal Medicine, University of Missouri Health Sciences
Center, Am J Kidney Dis 1994 Jan;23(1):86-90.
Arden SD; Roep BO;
Neophytou PI; Usac EF; et al., "Imogen 38: a novel 38-kD islet mitochondrial
autoantigen recognized by T cells from a newly diagnosed type 1 diabetic
patient," Department of Clinical Biochemistry, University of Cambridge,
Addenbrooke's Hospital, United Kingdom, J Clin Invest 1996 Jan 15;97(2):551-61.
Blackwood, A.L.,
M.D.; Manual of Materia Medica, Therapeutics and Pharmacology, Second
Edition, Chicago, 1922. Birk OS; Douek DC; Elias D; Takacs K; et al.,
"A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model,
"Medical Research Council Clinical Sciences Centre, Royal Postgraduate
Medical School, Hammersmith Hospital, London, United Kingdom, Proc Natl
Acad Sci U S A 1996 Feb 6;93(3):1032-7.
Clark, John Henry,
"Dictionary of Practical Materia Media," Ninth Edition, London, 1901.
Dewey,W.A., M.D.; Practical Homeopathic Therapeutics, Third Edition, San
Francisco, 1934.
Hancock WW; Polanski
M; Zhang J; Blogg N; Weiner HL, "Suppression of insulitis in non-obese
diabetic (NOD) mice by oral Insulin administration is associated with
selective expression of interleukin-4 and -10, transforming growth factor-beta,
and prostaglandin-E," Department of Pathology, New England Deaconess Hospital,
Boston, Am J Pathol 1995 Nov;147(5):1193-9.
Hermitte L; Atlan-Gepner
C; Payan MJ; Mehelleb M; Vialettes B, "Dietary protection against diabetes
in NOD mice: lack of a major change in the Immune System," Service de
Nutrition, Endocrinologie, Maladies metaboliques, Hospital Sainte-Marguerite,
Marseille, France, Diabete Metab 1995 Oct; 21(4):261-8.
Hopkins BA; Rakes
AH; Daniel TE; Zimmerman CA; Croom WJ Jr., "Effects of intraperitoneal
L-leucine, L-isoleucine, L-valine, and L-arginine on milk fat depression
in early lactation cows," Department of Animal Science, North Carolina
State University, J Dairy Sci 1994 Apr;77(4):1084-92.
Huges, Richard,
M.D., "Principles and Practice of of Homeopathy," fourth edition, London,
1901. Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; et al., "Autoimmune
diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha
(Lyt3.1) alleles of CD8,"Department of Pathology & Laboratory Medicine,
University of Florida College of Medicine, Immunogenetics 1996;43(1-2):6-12.
Kendrew, Sir John;
"The Encyclopedia of Molecular Biology," Blackwell Publishers, Oxford,
Oxfordshire, England, 1994.
Pieper GM; Jordan
M; Adams MB; Roza AM, "Syngeneic pancreatic islet transplantation reverses
endothelial dysfunction in experimental diabetes," Department of Transplant
Surgery, Medical College of Wisconsin, Diabetes 1995 Sep;44(9):1106-13.
Ruilope LM, "Effects
of angiotensin converting enzyme inhibitors on the progression of diabetic
nephropathy." Unidad de Hipertension, Hospital 12 de Octubre, Madrid,
Spain, J Hypertens Suppl 1995 Aug;13(2):S91-3.
Takacs K; Douek DC;
Altmann DM, "Exacerbated autoimmunity associated with a T helper-1 cytokine
profile shift in H-2E-transgenic mice," Clinical Sciences Centre, Royal
Postgraduate Medical School, Hammersmith Hospital, London, UK, Eur J Immunol
1995 Nov; 25 (11):3134-41.
Zipris D; Greiner
DL; Malkani S; Whalen B; et al., "Cytokine gene expression in islets and
thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in
both diabetic and Insulin-treated nondiabetic BB rats," Department of
Medicine, University of Massachusetts Medical Center, J Immunol 1996 Feb
1;156(3):1315-21.
|
|